Molecular tumor board members sitting around a table

Molecular Tumor Board

The Duke Molecular Tumor Board (DMTB) is a collaboration between the Duke Pathology Department and the Duke Cancer Institute (DCI). It was developed to foster precision medicine within the DCI. The goal of this effort is to match the most effective and safest therapy to each patient in real-time.

This page was reviewed on 11/15/2023